Asymptomatic hyperuricemia

2 papers1 finding

Humans2

Associations

1

Major adverse cardiovascular events

upin humans1

1 study

Asymptomatic hyperuricemia raises the risk of major adverse cardiovascular events in humans (aOR 5.77, 95% CI: 2.49-13.39).
“showed a significantly higher incidence of MACE than those without hyperuricemia (34.2% vs 8.6%; adjusted odds ratio 5.77, 95% CI: 2.49-13.39).”
Humansin patients with type 2 diabetesn = 247
Empagliflozin improves serum uric acid and early cardiometabolic outcomes in asymptomatic hyperuricemia among patients with type 2 diabetes: A 6-month observational study
Medicine11 Sep 2026

Trial sponsors

AstraZeneca
Company1 trialPhase 236 people

Latest

1 in 12 months

Medicine15 Sep

Empagliflozin improves serum uric acid and early cardiometabolic outcomes in asymptomatic hyperuricemia among patients with type 2 diabetes: A 6-month observational study

Cohort study of 247 peopleEmpagliflozin

Journal of the American Heart Association27 Mar

Exploration of the Interrelationship Between Serum Uric Acid, Gout, and Cardiac, Renal, and Metabolic Conditions in Middle Aged and Older People

Cohort study of 17,913 peopleKidney

European Journal of Clinical Nutrition20 Feb

Asymptomatic hyperuricemia and incident stroke in elderly Chinese patients without comorbidities

Cohort study of 3,243 peopleHyperuricemia